Clinical Trial Update: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) [Phase 4]

View source ↗

Summary

Phase 4 TRIM-AF trial update focusing on risk interventions and Metformin for atrial fibrillation; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Mina Chung, MD | Conditions: Atrial Fibrillation | Phase 4 | Status: ACTIVE_NOT_RECRUITING